Pantoprazole and Soluprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Soluprep (2%chlorhexidine gluconate;70% isopropyl alcohol). Common drug interactions include irritable bowel syndrome among females.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Soluprep. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,167 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Soluprep?

Soluprep has active ingredients of 2%chlorhexidine gluconate;70% isopropyl alcohol. eHealthMe is studying from 40 Soluprep users. Check the latest studies of Soluprep.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

33 people who take Pantoprazole and Soluprep together, and have interactions are studied.

Pantoprazole and Soluprep drug interactions.

What are the common drug interactions of Pantoprazole and Soluprep, by gender? *:

female:

  1. Irritable bowel syndrome
  2. Anti-cyclic citrullinated peptide antibody positive
  3. Pruritus (severe itching of the skin)
  4. Swelling
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Wound
  7. Infection
  8. Lower respiratory tract infection
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Pyrexia (fever)

male:

n/a

What are the common drug interactions of Pantoprazole and Soluprep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anti-cyclic citrullinated peptide antibody positive
  2. Drug intolerance (drug sensitivity)
  3. Pruritus (severe itching of the skin)
  4. Swelling
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Wound
  7. Infection
  8. Lower respiratory tract infection
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Pyrexia (fever)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 32 people, 96.97%
  2. Stress And Anxiety: 14 people, 42.42%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 42.42%
  4. Psoriasis (immune-mediated disease that affects the skin): 7 people, 21.21%
  5. Fever: 7 people, 21.21%
  6. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 6 people, 18.18%
  7. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 18.18%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 15.15%
  9. Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 15.15%
  10. Pain: 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Soluprep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pantoprazole and Soluprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soluprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soluprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and 2%chlorhexidine gluconate;70% isopropyl alcohol (the active ingredients of Pantoprazole and Soluprep, respectively), and Pantoprazole and Soluprep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: